Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following widespread use of pneumococcal

Michael S Benninger1

  • 1Head and Neck Institute, The Cleveland Clinic, Cleveland, OH 44195, USA. benninm@ccf.org

Abstract

Insights

The pneumococcal conjugate vaccine has reduced the incidence of pneumococcal otitis media and acute bacterial rhinosinusitis. However, shifts in pneumococcal serotypes and increasing prevalence of Haemophilus influenzae may impact future treatment strategies.

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Microbiology

Background:

  • Acute bacterial rhinosinusitis and acute otitis media are common infections.
  • Key pathogens include Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus.
  • Widespread pneumococcal conjugate vaccine use may alter pathogen distribution and serotypes.

Purpose of the Study:

  • To evaluate literature supporting changes in pathogenicity of these infections post-vaccine introduction.
  • To assess the impact of conjugate pneumococcal vaccine on bacterial distribution and resistance patterns.

Main Methods:

  • MEDLINE literature search conducted from 1995 to 2007.
  • Review focused on pathogen distribution, resistance rates, and pneumococcal serotype shifts before and after vaccine implementation.

Main Results:

  • Pneumococcal serotype distribution has changed, with a decrease in vaccine-type disease and evidence of herd immunity.
  • Increases in non-vaccine serotypes, some with high resistance, are noted.
  • Growing evidence suggests an increasing prevalence of Haemophilus influenzae in these infections.

Conclusions:

  • Conjugate pneumococcal vaccine use has decreased the incidence of pneumococcal otitis media and likely acute bacterial rhinosinusitis.
  • These shifts may necessitate adjustments in current treatment recommendations for these common infections.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...